Rodney A Ferguson
CIK 1266130 · last filed 2016-01-05
Rodney A Ferguson is a corporate insider who has filed 10 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing shows the insider was granted $25.0K of HTGZ on Jan 5, 2016. Across all open-market trades the lifetime net is −$10.3M, making them a net seller over the disclosed history. 4 SEC filings were submitted jointly with HERCULES TECHNOLOGY GROWTH CAPITAL INC.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ASPX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
50 CALIFORNIA STREET SUITE 2940
SAN FRANCISCO, CA 94111
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Hercules Capital, Inc. (HTGZ) Delisted | Director | 7,855 | — | — | $0 | 3 | 2016-01-05 |
| Auspex Pharmaceuticals, Inc. (ASPX) Delisted | Director | 2,500,589 | — | — | -$10.34M | 3 | 2015-05-06 |
| ANESIVA, INC. (ANSV) Delisted | Director | 136 | — | — | $0 | 4 | 2008-05-14 |
Recent Filings
10 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-01-05 | Hercules Capital, Inc. (HTGZ) Delisted | Grant (A) | +2,050 | $25.0K | EDGAR |
| 2015-10-02 | Hercules Capital, Inc. (HTGZ) Delisted | Grant (A) | +2,472 | $25.0K | EDGAR |
| 2015-07-09 | Hercules Capital, Inc. (HTGZ) Delisted | Grant (A) | +3,333 | $38.1K | EDGAR |
| 2015-05-06 | Auspex Pharmaceuticals, Inc. (ASPX) Delisted | U | −2,500,589 | $0 | EDGAR |
| 2015-01-28 | Auspex Pharmaceuticals, Inc. (ASPX) Delisted | Sell (S) | −270,000 | -$14.34M | EDGAR |
| 2014-02-12 | Auspex Pharmaceuticals, Inc. (ASPX) Delisted | Mixed | +2,770,589 | $4.00M | EDGAR |
| 2008-05-14 | ANESIVA, INC. (ANSV) Delisted | Grant (A) | +2,412,475 | $0 | EDGAR |
| 2008-05-14 | ANESIVA, INC. (ANSV) Delisted | Grant (A) | +2,412,475 | $0 | EDGAR |
| 2008-05-13 | ANESIVA, INC. (ANSV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-06-04 | ANESIVA, INC. (ANSV) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.